Short Summary
Eunsung Global Corp. petitions the PTAB to cancel HydraFacial's 11,446,477 skin‑treatment patent, alleging obviousness over several prior‑art references.
Detailed Summary
In Petition IPR2025-00453, Eunsung Global Corp. challenges HydraFacial LLC's U.S. Patent No. 11,446,477, which claims a skin‑treatment system with a manifold, handpiece, vacuum source, and control features. The petitioner asserts that claims 1‑20 are unpatentable under 35 U.S.C. §103, relying on combinations of prior art such as Karasiuk, Palmer, Trueba, Wunsch, and Greenberg. The petition argues the examiner erred by not rejecting the claims based on these references and requests cancellation of all challenged claims.
Practitioner Note
This case demonstrates the evidentiary and procedural standards applied in patent matters before local courts. Understanding the court's reasoning in Eunsung Global Corp. vs HydraFacial LLC et al. is valuable context for structuring arguments or assessing risk in similar proceedings.
Related Cases
Roku, Inc.vsAnonymous Media Research Holdings, LLC
Roku challenges a patent held by Anonymous Media Research Holdings, LLC in an IPR proceeding, asserting that the challenged claims related to audience measurement are obvious over prior art. Petitioner Roku relies on combinations of references like Feininger and Ramaswamy/Conklin to demonstrate predictable results in media playback analysis.
Apple Inc.vsCText IP LLC
Apple has filed an IPR petition challenging all 18 claims of CText IP's messaging patent, arguing they are obvious over prior‑art references Chang, Oh, and Stochosky. The petition seeks institution of the review and cancellation of the claims.
Google LLC et al.vsMullen Industries LLC
The Director denied requests for review in multiple IPR proceedings involving Google and Samsung against Mullen Industries regarding patent 11246024. The denial affirms the initial decision not to institute trial.
Imperative Care, Inc.vsInari Medical, Inc.
The PTAB instituted an inter partes review of Inari Medical’s 11,697,011 B2 hemostasis valve patent after finding Imperative Care’s likelihood of success on at least one claim.
Google LLC et al.vsPegasus Wireless Innovation LLC
The USPTO Director denied Google LLC's request for review of the PTAB's decision not to institute several telecom-related IPRs against Pegasus Wireless Innovation. The denial leaves the institution decisions unchanged.
Dealing with a patent challenge?
Whether it's a Section 3(d) rejection, a post-grant opposition, or a FRAND dispute, Arctic's patent litigation team has handled it. Get a strategy call.
Disclaimer: This page contains an automated summary based on publicly available judicial records. The content is generated for informational purposes only and does not constitute legal advice. Always verify details against the original source judgment before relying on this information for any legal purpose. If you believe any information is inaccurate, please contact us.